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Purpose: Recurrent carotid stenosis after carotid endarterectomy has been extensively 
reported. The occurrence, however, of another ipsilateral restenosis that requires a third 
carotid operation israre. The purpose of this study was to evaluate possible risk factors and 
the most efficacious management of the patient with "secondary" recurrent carotid 
stenosis. 
Methods: A survey of the Southern Association for Vascular Surgery was performed, and 31 
patients who had had surgery for secondary recurrent carotid stenosis were identified. 
Results: The mean interval between the recurrent stenosis operation and secondary 
recurrent carotid stenosis was 39.8 months (range, 9 to 83 months). At the third 
operation, 21 patients underwent carotid patch angioplasty and 10 underwent carotid 
resection with an interposition saphenous vein graft. No postoperative strokes or deaths 
occurred; three patients (10%) had a peripheral nerve injury. Nine early (<24 mo) secondary 
recurrent carotid stenoses occurred, and these patients underwent patch angioplasty. 
Twenty-three f male, cigarette-smoking patients and 20 patients with elevated lipid levels 
had early restenosis and were identified as being at high risk for the development of another 
stenosis. A fourth significant stenosis developed in five of these high-risk patients who had 
saphenous vein patch angioplasty at their third carotid operation; eight other high-risk 
patients had carotid resection with an interposition saphenous vein graft, and no other 
stenosis developed. 
Conclusion: Patients who have secondary recurrent carotid stenoses can safely undergo a
third carotid operation. Female habitual smokers with elevated lipid levels and an early 
restenosis appear to be at high risk of secondary ecurrent carotid stenoses. When surgery 
is necessary, carotid resection with an interposition saphenous vein graft appears more 
durable than patch angioplasty. (J Vasc Surg 1996;24:424-9.) 
The true incidence of  recurrent carotid stenosis 
after carotid endarterectomy (CEA) is unlmown, but 
symptomatic recurrent carotid stenosis has been re- 
ported to range from 0.6% to 3.6% 1'2 and asymptom- 
atic recurrent stenosis, based on noninvasive studies, 
from 8.8% to 19%. 3-5 
The occurrence of another ipsilateral recurrent 
stenosis that requires a third carotid operation is rare, 
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but the incidence of "secondary" recurrent carotid 
stenosis (SRCS) will likely increase with the wide- 
spread use of serial ultrasound surveillance examina- 
tions after carotid operations. The purpose of this 
study, which has not been previously reported, was to 
evaluate the possible risk factors and most appropriate 
operative management of the patient who has an 
SRCS. 
MATERIALS AND METHODS 
A survey of the Southern Association for Vascular 
Surgery membership wasperformed, and 15 surgeons 
(Joseph P. Archie, Jr., Raleigh, N.C.; Mario H. Avila, 
Tamarac, Fla.; Dennis E. Bandyk, Tampa, Fla.; 
J. Donald Carmichael, Birmingham, Ala.; G. Patrick 
Clagett, Dallas, Tex.; Jack L. Hamman, Madisonville, 
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Interval between operations (mo) 73,1 39.8 
Age (yr) 59.9 64.5 
Abnormal lipid profiles 20 (64%) 20 (64%) 
Female 23 (74%) 23 (74%) 
Coronary disease 14 (45%) 17 (55%) 
Hypertension 10 (32%) 13 (42%) 
Diabetes rnellitus 6 (19%) 8 (26%) 
Smoking 19 (61%) 23 (74%) 
Ky.; Hyung M. Lee, Richmond,Va.; Paul R. Liebman, 
West Palm Beach, Fla.; Joseph L. Mills, Tampa, Fla.; 
Stanley L. Minken, Baltimore, Md.; Georgia W. 
Plonk, Winston-Salem, N.C.; Marc P. Posner, Rich- 
mond, Va.; David Rosenthal, Atlanta, Ga.; Robert B. 
Smith, III, Atlanta, Ga.; and S. Timothy String, 
Mobile, Ala.) identified 31 patients who had under- 
gone operations for SRCS. 
After the initial CEA, the mean interval until a 
recurrent carotid stenosis developed was 73.1 months 
(range, 11 to 168 months); five recurred within 24 
months. The patients' mean age at the second carotid 
operation was 59.9 years (range, 44 to 73 years). The 
risk-facto.r characteristics with regard to lipid profile, 
gender, coronary artery heart disease, hypertension, 
diabetes mellitus, and smoldng are listed in Table I. 
Indications for second operation included hemi- 
spheric transient ischemic attacks (TIAs) in 14 pa- 
tients, asymptomatic arteriographic high-grade 
stenosis (,>75% reduction in diameter of the carotid 
artery at the point of maximal stenosis compared with 
the diameter of normal artery) in five patients, amau- 
rosis fugax in four patients, vertebrobasilar insuffi- 
ciency symptoms inthree patients, reversible ischemic 
neurologic deficit in three patients, and cerebrovas- 
cular accident in two patients. At the second opera- 
tion, 11 patients underwent repeat CEA and patch 
angioplasty (five with saphenous vein, four with 
Dacron, two with polytetrafluoroethylene [PTFE]), 
whereas 19 patients underwent carotid patch angio- 
plasty alone (12 with saphenous vein, four with 
Dacron, three with PTFE) and one patient under- 
went carotid resection with an interposition saphe- 
nous vein graft (Table II). No strokes or deaths 
occurred after operation; however, one patient had a 
TIA that resolved uneventfully and two patients 
sustained cranial nerve injuries (Table III). All pa- 
tients were given aspirin after surgery. 
The mean interval between the recurrent s enosis 
Table II. Operative procedures 







"Repeat" CEA with patch angioplasty 11 
Patch angioplasty alone 19 21 
Carotid resection/interposition graft 1 10 
operation and SRCS was 39.8 months (range, 9 to 83 
months). In nine patients SRCS occurred within 24 
months of the second operation. The mean age at the 
third operation was 64.5 years (range, 45 to 76 years). 
The risk-factor characteristics are listed in Table I. 
Indications for a third operation included amaurosis 
fugax in 13 patients, asymptomatic arteriographic 
high-grade stenosis (>75%) in 11 patients, hemi- 
spheric TIAs in six patients, and a stroke in one 
patient. All patients underwent an arteriographic 
examination toconfirm the diagnosis of SRCS and to 
determine the degree ofstenosis. After operation for 
SRCS, all patients continued a regimen of aspirin, and 
all patients had follow-up duplex examinations. These 
patients were considered athigh risk for the develop- 
ment of another ecurrent stenosis and underwent 
carotid duplex ultrasonography surveillance on aver- 
age 6.8 times per patient between their recurrent 
stenosis operation and SRCS. Statistical analysis was 
performed by the life-table method where appropri- 
ate. Because patient selection was not randomized, 
any statistical conclusions must be guarded. 
RESULTS 
Thirty-one patients underwent operations for 
SRCS. At the third operation, 21 patients underwent 
carotid patch angioplasty (16 with saphenous vein, 
three with Dacron, two with PTFE) and 10 under- 
went carotid resection with interposition saphenous 
vein grafts (Table II). No postoperative strokes or 
deaths occurred; however, three patients (10%) had 
traction cranial nerve injuries (two vagal, one hypo- 
glossal) that resolved uneventfully (Table III). 
Of these 31 patients, 23 were female habitual 
cigarette smokers, and 20 had elevated serum lipid 
levels. With this risk-factor profile such patients were 
considered to be at high risk for the development of
another recurrent stenosis (Table IV). These 23 
patients underwent carotid patch angioplasty (15) or 
carotid resection with an interposition saphenous vein 
graft (8) at the third operation. None of these 
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Table I lL Operative results 
Secondary 
Postoperative Recurrent recurrent 
complication carotid carotid 
(n = 31) stenosis stenosis 
Cranial nerve injury 2 (6%) 3 (10%) 
T~ 1 (3%) 0 
Cerebrovascular ccident 0 0 
Death 0 0 
high-risk patients who had carotid resection with an 
interposition saphenous vein graft at the third opera- 
tion had another ecurrent stenosis. However, five of 
the patients who had carotid patch angioplasty at the 
third operation (four with saphenous vein, one with 
Dacron) had another ecurrent stenosis (>75% diam- 
eter) documented by carotid ultrasonography. Four 
patients in this subgroup ultimately underwent ca- 
rotid resection with a saphenous vein interposition 
graft (three for a symptomatic high-grade stenosis, 
one for TIAs), and the fifth patient refused operation 
despite TIA symptoms. The four carotid resection 
patients have had serial ultrasonography surveillance; 
no recurrent stenosis developed in follow-up extend- 
ing to 30 months. Eight male patients with SRCS had 
either elevated lipid levels or were smokers, but not 
both risk factors together. None of these male patients 
had another ecurrent stenosis. 
It was of interest o note that the mean interval 
between the recurrent carotid stenosis and the SRCS 
(39.8 months) was approximately half the interval 
between the initial CEA and development ofa recur- 
rent carotid stenosis (mean, 73.1 months). Nine of 
the SRCSs occurred within 24 months of the second 
carotid operation and were believed to be caused by 
myointimal hyperplasia. In seven of these patients, the 
SRCS was noted to have occurred at the previous 
repeat CEA or patch graft angioplasty site. The 
indications for operation among these nine early 
restenotic patients were asymptomatic stenosis >75% 
in 7 patients, amaurosis fugax in one, and stroke in 
one. These nine patients underwent carotid patch 
angioplasty atthe third operation (six with saphenous 
vein, two with Dacron, one with PTFE). Four of these 
patients who had patch angioplasty for early restenosis 
had a fourth stenosis; all four patients were in the 
high-risk category (female, habitual cigarette smok- 
ing, elevated lipid levels). Twenty-two ther patients 
had surgery for SRCS 24 months or later. In 17 of 
these patients the SRCS was noted to occur primarily 
at the proximal and distal repeat CEA or patch graft 
angioplasty sites. The indications for operation in 
Table IV. High-risk patient/operation 
Fourth Fourth 
Third operation carotid operation Fifth 








4 Carotid/resection None 
1 SV graft 
None 
SV, Saphenous vein. 
these patients were morc consistent with recurrent 
atherosclerotic embolic-type symptoms, which in- 
cluded amaurosis fugax in I2 patients, hemispheric 
TIAs in six, and asymptomatic high-grade stenosis in 
four. After these 22 operations (10 carotid resections 
with saphenous vein interposition grafts; 10 saphe- 
nous vein, one Dacron, and one PTFE patch angio- 
plasties), only one patient who underwent a saphe- 
nous vein patch angioplasty had a fourth stenosis. 
During follow-up (mean, 40.4 months; range, 
1 to 96 months) after surgery for SRCS, one patient 
had an ipsilateral stroke. This patient had undergone 
carotid resection with a saphenous vein interposition 
graft 31 months earlier. Arteriography demonstrated 
a patent bypass graft; however, proximal common 
carotid ulcerated occlusive disease was identified. 
The patient refused another operation. Five deaths 
occurred during follow-up, none related to stroke 
(Fig. 1). 
DISCUSSION 
Many previous publications have dealt with the 
symptoms, pathologic ondition, and operative re- 
sults associated with recurrent carotid stenosis after 
CEA. To our knowledge, however, no publication 
has solely addressed the rare occurrence of another 
ipsilateral recurrent stenosis that required a third 
operation. 
The cause of SRCS is unknown, but like recurrent 
carotid stenosis, it may be related to local factors, 
systemic factors, or both. At the time of the operation 
for recurrent carotid stenosis, local factors include 
repeat CEA, which may create foci for SRCS as a result 
of damp trauma, residual plaque, or intimal flaps at 
the repeat CEA site. When repeat CEAis not possible, 
carotid patch angioplasty has been advocated by 
several authors, 6-s especially for myointimal hyperpla- 
sia where an endarterectomy plane cannot be estab- 
lished. After carotid patch angioplasty, however; local 
geometry changes in the configuration of the artery 
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Fig. 1. Survival and stroke-free interval after operation for SRCS. 
can occur, which may lead to altered hemodynamics 
with laminated thrombus formation and, ultimately, 
an SRCS. In this study 21 patients underwent carotid 
patch angioplasty alone at the third operation, and a 
fourth carotid stenosis developed in five of these 
patients. 'This finding would suggest that carotid 
patch angioplasty may be an inadequate operation for 
patients who have SRCS. 
Carotid resection with the placement of an inter- 
position graft is another surgical option. This option 
historically has been reserved for those patients in 
whom repeat CEA or patch angioplasty is not possible 
either because the luminal surface is too diseased or 
the arterM wall is too scarred or thin. Treiman et al. 9 
demonstrated that carotid resection with saphenous 
vein interposition graft placement is as safe and 
effective as repeat CEA with patch angioplasty and 
should be used when repeat CEA cannot be per- 
formed. Sise et al.10 advocated the use of PTFE 
interposition grafts for carotid reconstruction; how- 
ever, one third of patients who underwent carotid 
resection and interposition PTFE grafting procedures 
for recurrent carotid stenosis had an SRCS. Ten 
patients in this study underwent carotid resection 
with an interposition saphenous vein graft at the third 
operation, and one had another stenosis. Raithel, 1~ 
however, reported a series of 43 patients who under- 
went PTFE interposition grafting procedures for 
recurrent carotid stenosis; an SRCS did not develop in 
any of these patients. 
Contradictory data have been presented that de- 
fine systemic risk factors, but female gender, contin- 
ued cigarette smoking after CEA, young age at the 
time of initial presentation, hyperlipidemia, hyperten- 
sion, and diabetes have all been implicated321s It was 
of interest o note that all patients in this series who 
had SRCS also had at least hree of these risk factors, 
with female gender (74%), continued cigarette smok- 
ing (74%), and abnormal lipid profiles (64%) being 
the most common (Table I). 
It has been generally accepted that myointimal 
hyperplasia is responsible for early (<24 mo) recurrent 
carotid stenosis, whereas late recurrent carotid steno- 
sis is generally atherosclerotic in nature. SRCS caused 
by myointimal hyperplasia usually involves the entire 
arterial wall in exuberant scar. It was noted that when 
early SRCS occurred itwas located at the endarterec- 
tomy site, whereas late SRCS was more pronounced at
the proximal and distal endarterectomy endpoints. 
Symptomatically, patients who had early SRCS "be- 
haved" differently than patients with late SRCS. For 
example, only two patients who had early SRCS also 
had embolic type symptoms (one with amaurosis 
fugax, one with stroke), compared with 18 late SRCS 
patients (12 with amaurosis fugax, 6 with TIAs), 
which may be explained on the basis of arterial 
morphologic haracteristics. Bernstein et al. 16 theo- 
rized that the myointimal coveting of an early recur- 
rent stenotic artery may inhibit the subsequent devel- 
opment of progressive atherosclerosis, with degenera- 
tive change and, ultimately, embolization. Although 
it is difficult o draw definitive conclusions about he 
necessity for operation in these patients, asymptom- 
atic patients who have an early SRCS may not warrant 
another operation as they may be protected against 
future embolic events. Operation in such patients may 
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only be necessary if symptoms occur, but this remains 
to be proved. 
In this study, 21 patients underwent carotid patch 
angioplasty and 10 underwent carotid resection with 
interposition saphenous vein graft at the third opera- 
tion. Mthough these operations were safe (no post- 
operative strokes or deaths) and durable (one late 
stroke caused by progression of  proximal carotid 
artery disease), a fourth stenosis developed in five 
female cigarette-smoking patients with elevated lipid 
levels in whom an early SRCS had developed and who 
had carotid patch angioplasty at their third operation 
(Table IV). Women, in general, appear to be at higher 
risk for the development of  myointimal hyperplasia 
after carotid operations. Ten Holter et al.17 reported 
a 14% recurrent stenosis rate in women compared 
with a 9% rate in men during the first year after CEA; 
after the first year, however, the recurrent stenosis 
rates were equivalent. 
Thus the female patient who has an early SRCS 
with the additional risk factors o f  continued cigarette 
smoking and abnormal lipid profile appears to be at 
very high risk to have another ecurrent stenosis. In  
this difficult subset o f  patients, caution is warranted in 
recommending prophylactic operation for an asymp- 
tomatic stenosis. When operation is necessary, how- 
ever, carotid resection with an interposition saphe- 
nous vein graft appears more durable than patch 
angioplasty. Risk-factor modification may ultimately 
be the most effective means of  preventing SRCS, but 
this possible solution requires further investigation. 
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DISCUSSION 
Dr. Williams H. Edwards, St. (Nashville, Tenn.). I 
appreciate the opportunity to discuss this paper on "sec- 
ondary" recurrent carotid stenosis. I congratulate Dr. 
Rosenthal on putting together this group of patients. It is 
difficult to direct questions to the shepherd who has 
assembled such a heterogenous group of sheep. Dr. 
Rosenthal has covered the salient features and has pointed 
out the dangers of drawing statistical conclusions from this 
heterogeneous group of patients. 
The first report that described symptomatic recurrent 
carotid stenosis after CEA was written by Sterling Edwards 
in 1968. He reported in 1987 a study that was carried out 
to evaluate techniques to widen the carotid bifurcation with 
autologous material to determine whether the incidence of 
recurrent stenosis could be reduced. The total number of 
patients he studied was small, and follow-up with ultra- 
sonography was fairly short. He found, however, that there 
was no difference in recurrent significant stenosis, the range 
being 12% to 16%. 
Many reports of recurrent symptomatic carotid stenosis 
have tried to incriminate the usual risk factors--hyperlip- 
idemia, hypertension, smoking, small internal carotid ar- 
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tery, female gender--as being the primary causes for recur- 
rence. In Dr. Rosenthal's collection of patients, the primary 
risk factors were hyperlipidemia, female gender, and heavy 
smoking. 
Because there does not appear to be one systemic factor 
that stands out, I think the algorithm presented by Dr. 
Clagett in his article presented at the ISCVS meeting in 
1985 is a reasonable approach. He divided the factors into 
local and systemic; the local factors being ongoing throm- 
bogenesis and the neointimal fibromuscular hyperplasia 
progressing to degeneration a d a complex atherosclerotic 
lesion. This begins immediately after the CEA. Add to these 
the factors of clamp trauma or an intimal flap and the 
incidence ofrestenosis  probably increased. The systemic 
factors of gender, smoking, hyperlipidemia, and--probably 
the most significant--the atherosclerotic predisposition of
the genes that we bring into life cause recurrent atherosde- 
rotic disease',. 
In this same article, Dr. Clagett pointed out that there 
were morphologic differences between the early recur- 
rences and late recurrences, uch as the pale white rubbery 
hyperplastic lesion densely adherent to the arterial wall that 
with time will probably undergo subintimal thrombosis and 
degenerate into atherosclerotic plaque. 
CEA is the most frequently performed peripheral vas- 
cular procedure. With randomized, controlled studies that 
prove the efficacy of CEA, both symptomatic and asymp- 
tomatic, we can say that we are going to continue to see 
symptomatic recurrent carotid stenosis. 
Fortunately, SRCS is unusual. In our series of CEAs 
dating back to 1973, our rate of recurrent first-time 
symptomatic carotid artery stenosis was in the range of 3% 
to 4%; however, of those patients with one recurrence, 
about 23% are candidates for a secondary recurrence. 
During this time period, we performed a resection of the 
carotid bifurcation and vcin interposition on 36 occasions in 
29 patients for SRCS. We first rcported this in 1987. In 
1989 we recommended that resection of the carotid bifur- 
cation with vein interposition was a safe and durable 
alternative tomultiple recurrent CEAs, patch or no patch. I 
mentioned in that article that orthograde placement of the 
vein would give a bettcr anastomotic match than reversing 
thc saphenous vein. I still believe that this is appropriate if 
the valves can be adequately sed. 
In 1992 we again reported on the management of 
recurrent carotid artery stenosis, at which time we had 
performed 57 vein interpositions. Of those 57, 20 were for 
secondary symptomatic stenosis. Follow-up of those 20 
patients has revealed one operation for thrombus formation 
at a valve. One vein had to be removed because of 
aneurysmal dilatation, and stenosis <50% has occurred in 
four additional veins. 
The first patient we operated on with vein interposition 
was in 1983 for secondary stenosis. She did well and died in 
1993 of coronary artery disease. The second patient who 
also underwent surgery in 1983 is still alive with no 
recurrent stenosis. 
A comment on the surgical technique: this can be a 
difficult and tedious operation, but sometimes it is amaz- 
ingly simple. Sometimes these carotid bifurcations in the 
internal carotid artery can be dissected very easily. Care 
must be taken, however, not to dissect subadventitially 
because then you have a problem. This will require higher 
dissection until you have good distal artery to which you can 
hopefully interpose a vein. 
These can be challenging patients to manage. I would, 
however, not necessarily caution against he operation for 
SRCS. Ira patient is asymptomatic but has a high degree of 
stenosis, I think that the risks of operation still are less than 
the risk of patients having stroke. 
